Addiction

Disease

Disease Profile

Addiction is a chronic, relapsing disorder characterized by compulsive substance seeking and use despite harmful consequences. It is associated with persistent brain and behavioral changes and often requires long-term management.

Category
Mental, behavioral and neurodevelopmental disorders (substance-related)
ICD Codes
  • F10-F19

Related News

Major Drug Busts in New Zealand and Canada Seize Cocaine, Meth, Fentanyl

New Zealand police arrested 11 people and seized drugs, cash, and firearms after uncovering a dark web drug import network, while Canadian police made a separate bust seizing cocaine, fentanyl, and methamphetamine. The New Zealand operation involved international cooperation and intercepted over 200kg of drugs at borders. The busts come as New Zealand data shows record-breaking cocaine consumption nationwide.

GLP-1 Drugs Show Promise in Treating Addiction Across Multiple Substances

A study of over 600,000 patients reveals GLP-1 drugs may reduce addiction across multiple substances, with 50% fewer substance-related deaths and significant reductions in overdoses and hospitalizations. The drugs work by dampening dopamine signaling in brain reward centers. Researchers are exploring broader applications for these medications beyond diabetes and obesity treatment.

Psychedelic Therapies Show Promise for Depression, Anxiety and Addiction

Clinical trials show psychedelic substances like psilocybin, LSD and MDMA combined with therapy can effectively treat depression, anxiety and addiction. Several substances are in Phase III trials, with esketamine already approved for treatment-resistant depression. Research suggests these treatments may work with fewer doses than traditional medications.

Ketamine's Therapeutic Benefits Not Linked to Psychedelic Effects in Alcohol Use Disorder

New research challenges the theory that ketamine's psychedelic effects drive its therapeutic benefits for alcohol use disorder. A study of 96 participants found no link between ketamine's psychoactive experiences and improved abstinence rates. The findings suggest other mechanisms, such as brain network alterations, may explain ketamine's effectiveness in treating addiction.

Related Clinical Trials

NCT ID Title Status Phase
NCT07596251

Support Towards Addiction Recovery for Individuals With Criminal Legal System Involvement: The STAR Project

NOT_YET_RECRUITING NA
NCT07595614

NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD

RECRUITING
NCT07590154

Cross-sectional Functional Stratification Based on Psychometric Profiling and Machine Learning in Patients With Substance Use Disorders (SUD)

COMPLETED
NCT07585006

Comparative Evaluation of Nicotine Analogs

NOT_YET_RECRUITING PHASE1
NCT07573345

Pain and Upper Extremity Function in Smartphone and Digital Game Addiction

RECRUITING
NCT07520617

Evaluation of the ADD'Pro Vocational Reintegration Program (ADD-PRO-EVAL)

NOT_YET_RECRUITING NA
NCT07510256

Effects of Breathwork and Meditation on Addiction Recovery

COMPLETED NA
NCT07495839

The Impact of Equine-Assisted Therapy on Mental Health and Addictive Behaviors in Patients Receiving Addiction Treatment

NOT_YET_RECRUITING NA
NCT07374666

The Effectiveness of a Mindfulness Based Program on Short- Form Video Addiction in Adolescents

ACTIVE_NOT_RECRUITING NA
NCT07340554

Neuroimaging of Adolescent Cannabis Use Treatment

RECRUITING NA